{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:14:17Z","timestamp":1759032857860},"reference-count":189,"publisher":"Japan Academy","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Proc. Jpn. Acad., Ser. B","Proceedings of the Japan Academy. Ser. B: Physical and Biological Sciences"],"published-print":{"date-parts":[[2019,11,11]]},"DOI":"10.2183\/pjab.95.037","type":"journal-article","created":{"date-parts":[[2019,11,10]],"date-time":"2019-11-10T22:03:40Z","timestamp":1573423420000},"page":"538-567","source":"Crossref","is-referenced-by-count":10,"title":["Translational science: Newly emerging science in biology and medicine \u2014 Lessons from translational research on the natriuretic peptide family and leptin \u2014"],"prefix":"10.2183","volume":"95","author":[{"given":"Kazuwa","family":"NAKAO","sequence":"first","affiliation":[{"name":"Medical Innovation Center, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"993","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Sung, N.S., Crowley, W.F. Jr., Genel, M., Salber, P., Sandy, L., Sherwood, L.M.  (2003) Central challenges facing the national clinical research enterprise. JAMA 289, 1278\u20131287.","DOI":"10.1001\/jama.289.10.1278"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Nakao, K., Yasoda, A., Ebihara, K., Hosoda, K. and Mukoyama, M. (2009) Translational research of novel hormones: Lessons from animal models and rare human diseases for common human diseases. J. Mol. Med. 87, 1029\u20131039.","DOI":"10.1007\/s00109-009-0515-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Austin, P.C. (2018) Translating translation. Nat. Rev. Drug Discov. 17, 455\u2013456.","DOI":"10.1038\/nrd.2018.27"},{"key":"4","unstructured":"4) Okamoto, K. and Aoki, K. (1963) Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27, 282\u2013293."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ingalls, A.M., Dickie, M.M. and Snell, G.D. (1950) Obese, a new mutation in the house mouse. J. Hered. 41, 317\u2013318.","DOI":"10.1093\/oxfordjournals.jhered.a106073"},{"key":"6","unstructured":"6) https:\/\/ncats.nih.gov\/translation."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Takamine, J. (1902) The blood-pressure raising principle in the suprarenal gland. J. Am. Med. Assoc. 38, 153\u2013155.","DOI":"10.1001\/jama.1902.62480030011001c"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nakao, K., Ogawa, Y., Suga, S. and Imura, H. (1992) Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J. Hypertens. 10, 907\u2013912.","DOI":"10.1097\/00004872-199209000-00001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nakao, K., Ogawa, Y., Suga, S. and Imura, H. (1992) Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors. J. Hypertens. 10, 1111\u20131114.","DOI":"10.1097\/00004872-199210000-00002"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10) Suga, S., Nakao, K., Hosoda, K., Mukoyama, M., Ogawa, Y., Shirakami, G.  (1992) Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130, 229\u2013239.","DOI":"10.1210\/en.130.1.229"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sugawara, A., Nakao, K., Morii, N., Yamada, T., Itoh, H., Shiono, S.  (1988) Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of \u03b2-human ANP. J. Clin. Invest. 81, 1962\u20131970.","DOI":"10.1172\/JCI113544"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Saito, Y., Nakao, K., Arai, H., Nishimura, K., Okumura, K., Obata, K.  (1989) Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J. Clin. Invest. 83, 298\u2013305.","DOI":"10.1172\/JCI113872"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Mukoyama, M., Nakao, K., Saito, Y., Ogawa, Y., Hosoda, K., Suga, S.  (1990) Human brain natriuretic peptide, a novel cardiac hormone. Lancet 335, 801\u2013802.","DOI":"10.1016\/0140-6736(90)90925-U"},{"key":"14","unstructured":"14) Mukoyama, M., Nakao, K., Saito, Y., Ogawa, Y., Hosoda, K., Suga, S.  (1990) Increased human brain natriuretic peptide in congestive heart failure. N. Engl. J. Med. 323, 757\u2013758."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y.  (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87, 1402\u20131412.","DOI":"10.1172\/JCI115146"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Morita, E., Yasue, H., Yoshimura, M., Ogawa, H., Jougasaki, M., Matsumura, T.  (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88, 82\u201391.","DOI":"10.1161\/01.CIR.88.1.82"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17) Kawakami, R., Saito, Y., Kishimoto, I., Harada, M., Kuwahara, K., Takahashi, N.  (2004) Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction. Circulation 110, 3306\u20133312.","DOI":"10.1161\/01.CIR.0000147829.78357.C5"},{"key":"18","unstructured":"18) Arai, H., Nakao, K., Saito, Y., Morii, N., Sugawara, A., Yamada, T.  (1988) Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone. Circ. Res. 62, 926\u2013930."},{"key":"19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","volume":"90","author":"H. Yasue","year":"1994","unstructured":"19) Yasue, H., Yoshimura, M., Sumida, H., Kikuta, K., Kugiyama, K., Jougasaki, M.  (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90, 195\u2013203.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(85)92592-9","volume":"2","author":"A. Sugawara","year":"1985","unstructured":"20) Sugawara, A., Nakao, K., Sakamoto, M., Morii, N., Yamada, T., Itoh, H.  (1985) Plasma concentration of atrial natriuretic polypeptide in essential hypertension. Lancet 2, 1426\u20131427.","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Itoh, H., Nakao, K., Mukoyama, M., Yamada, T., Hosoda, K., Shirakami, G.  (1989) Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. J. Clin. Invest. 84, 145\u2013154.","DOI":"10.1172\/JCI114134"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Ogawa, Y., Nakao, K., Mukoyama, M., Hosoda, K., Shirakami, G., Arai, H.  (1991) Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ. Res. 69, 491\u2013500.","DOI":"10.1161\/01.RES.69.2.491"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kawai, M., Yoshimura, M., Harada, M., Mizuno, Y., Hiramitsu, S., Shimizu, M.  (2013) Determination of the B-type natriuretic peptide level as a criterion for abnormalities in Japanese individuals in routine clinical practice: The J-ABS multi-center study (Japan Abnormal BNP Standard). Intern. Med. 52, 171\u2013177.","DOI":"10.2169\/internalmedicine.52.8704"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24) Saito, Y., Nakao, K., Nishimura, K., Sugawara, A., Okumura, K., Obata, K.  (1987) Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function. Circulation 76, 115\u2013124.","DOI":"10.1161\/01.CIR.76.1.115"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25) Yoshimura, M., Yasue, H., Morita, E., Sakaino, N., Jougasaki, M., Kurose, M.  (1991) Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84, 1581\u20131588.","DOI":"10.1161\/01.CIR.84.4.1581"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nishikimi, T., Nakagawa, Y., Minamino, N., Ikeda, M., Tabei, K., Fujishima, A.  (2015) Pro-B-type natriuretic peptide is cleaved intracellularly: Impact of distance between <i>O<\/i>-glycosylation and cleavage sites. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309, R639\u2013R649.","DOI":"10.1152\/ajpregu.00074.2015"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nishikimi, T., Ikeda, M., Takeda, Y., Ishimitsu, T., Shibasaki, I., Fukuda, H.  (2012) The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure. Heart 98, 152\u2013161.","DOI":"10.1136\/heartjnl-2011-300102"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nishikimi, T., Okamoto, H., Nakamura, M., Ogawa, N., Horii, K., Nagata, K.  (2013) Direct immunochemiluminescent assay for proBNP and total BNP in human plasma proBNP and total BNP levels in normal and heart failure. PLoS One 8, e53233.","DOI":"10.1371\/journal.pone.0053233"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nishikimi, T., Kuwahara, K., Nakagawa, Y., Kangawa, K., Minamino, N. and Nakao, K. (2013) Complexity of molecular forms of B-type natriuretic peptide in heart failure. Heart 99, 677\u2013679.","DOI":"10.1136\/heartjnl-2012-302929"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Nakagawa, Y., Nishikimi, T., Kuwahara, K., Fujishima, A., Oka, S., Tsutamoto, T.  (2017) MiR30-GALNT1\/2 Axis-mediated glycosylation contributes to the increased secretion of inactive human prohormone for brain natriuretic peptide (proBNP) from failing hearts. J. Am. Heart Assoc. 6, e003601.","DOI":"10.1161\/JAHA.116.003601"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Nakagawa, Y., Nishikimi, T., Kuwahara, K., Yasuno, S., Kinoshita, H., Kuwabara, Y.  (2014) The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis. PLoS One 9, e92314.","DOI":"10.1371\/journal.pone.0092314"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32) Li, Y., Saito, Y., Kuwahara, K., Rong, X., Kishimoto, I., Harada, H.  (2009) Natriuretic peptide receptor\/guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart. Endocrinology 150, 3759\u20133765.","DOI":"10.1210\/en.2008-1353"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kinoshita, H., Kuwahara, K., Nishida, M., Jian, Z., Rong, X., Kiyonaka, S.  (2010) Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart. Circ. Res. 106, 1849\u20131860.","DOI":"10.1161\/CIRCRESAHA.109.208314"},{"key":"34","unstructured":"34) Ogawa, Y., Mukoyama, M., Yokoi, H., Kasahara, M., Mori, K., Kato, Y.  (2012) Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J. Am. Soc. Nephrol. 23, 1198\u20131209."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kato, Y., Mori, K., Kasahara, M., Osaki, K., Ishii, A., Mori, K.P.  (2017) Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition. Sci. Rep. 7, 46624.","DOI":"10.1038\/srep46624"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36) Miyashita, K., Itoh, H., Tsujimoto, H., Tamura, N., Fukunaga, Y., Sone, M.  (2009) Natriuretic peptides\/cGMP\/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 58, 2880\u20132892.","DOI":"10.2337\/db09-0393"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Sonoyama, T., Tamura, N., Miyashita, K., Park, K., Oyamada, N., Taura, D.  (2009) Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide. FEBS Lett. 583, 2067\u20132070.","DOI":"10.1016\/j.febslet.2009.05.025"},{"key":"38","unstructured":"38) Sudoh, T., Minamino, N., Kangawa, K. and Matsuo, H. (1990) C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168, 863\u2013870."},{"key":"39","doi-asserted-by":"publisher","unstructured":"39) Komatsu, Y., Nakao, K., Suga, S., Ogawa, Y., Mukoyama, M., Arai, H.  (1991) C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 129, 1104\u20131106.","DOI":"10.1210\/endo-129-2-1104"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Suga, S., Nakao, K., Itoh, H., Komatsu, Y., Ogawa, Y., Hama, N.  (1992) Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-\u03b2. Possible existence of \u201cvascular natriuretic peptide system\u201d. J. Clin. Invest. 90, 1145\u20131149.","DOI":"10.1172\/JCI115933"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41) Suga, S., Itoh, H., Komatsu, Y., Ogawa, Y., Hama, N., Yoshimasa, T.  (1993) Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells--evidence for CNP as a novel autocrine\/paracrine regulator from endothelial cells. Endocrinology 133, 3038\u20133041.","DOI":"10.1210\/en.133.6.3038"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42) Komatsu, Y., Nakao, K., Itoh, H., Suga, S., Ogawa, Y. and Imura, H. (1992) Vascular natriuretic peptide. Lancet 340, 622.","DOI":"10.1016\/0140-6736(92)92167-E"},{"key":"43","unstructured":"43) Kubo, A., Isumi, Y., Ishizaka, Y., Tomoda, Y., Kangawa, K., Dohi, K.  (2001) C-type natriuretic peptide is synthesized and secreted from leukemia cell lines, peripheral blood cells, and peritoneal macrophages. Exp. Hematol. 29, 609\u2013615."},{"key":"44","unstructured":"44) Komatsu, Y., Itoh, H., Suga, S., Ogawa, Y., Hama, N., Kishimoto, I.  (1996) Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition. Circ. Res. 78, 606\u2013614."},{"key":"45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/01.HYP.27.3.811","volume":"27","author":"K. Doi","year":"1996","unstructured":"45) Doi, K., Itoh, H., Komatsu, Y., Igaki, T., Chun, T.H., Takaya, K.  (1996) Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion. Hypertension 27, 811\u2013815.","journal-title":"Hypertension","ISSN":"http:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Hama, N., Itoh, H., Shirakami, G., Suga, S., Komatsu, Y., Yoshimasa, T.  (1994) Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem. Biophys. Res. Commun. 198, 1177\u20131182.","DOI":"10.1006\/bbrc.1994.1166"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Nakao, K., Kuwahara, K., Nishikimi, T., Nakagawa, Y., Kinoshita, H., Minami, T.  (2017) Endothelium-derived C-type natriuretic peptide contributes to blood pressure regulation by maintaining endothelial integrity. Hypertension 69, 286\u2013296.","DOI":"10.1161\/HYPERTENSIONAHA.116.08219"},{"key":"48","unstructured":"48) Yamahara, K., Itoh, H., Chun, T.H., Ogawam, Y., Yamashita, J., Sawada, N.  (2003) Significance and therapeutic potential of the natriuretic peptides\/cGMP\/cGMP-dependent protein kinase pathway in vascular regeneration. Proc. Natl. Acad. Sci. U.S.A. 100, 3404\u20133409."},{"key":"49","unstructured":"49) Chusho, H., Tamura, N., Ogawa, Y., Yasoda, A., Suda, M., Miyazawa, T.  (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc. Natl. Acad. Sci. U.S.A. 98, 4016\u20134021."},{"key":"50","doi-asserted-by":"publisher","unstructured":"50) Kronenberg, H.M. (2003) Developmental regulation of the growth plate. Nature 423, 332\u2013336.","DOI":"10.1038\/nature01657"},{"key":"51","unstructured":"51) Yasoda, A., Komatsu, Y., Chusho, H., Miyazawa, T., Ozasa, A., Miura, M.  (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med. 10, 80\u201386."},{"key":"52","unstructured":"52) Yasoda, A. and Nakao, K. (2010) Genetic basis for skeletal disease. CNP therapy for achondroplasia. Clin. Calcium 20, 1212\u20131218."},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Yasoda, A. and Nakao, K. (2015) Translational research of the activation of the C-type natriuretic peptide (CNP)-guanylyl cyclase-B pathway for skeletal dysplasia. <i>In<\/i> Innovative Medicine: Basic Research and Development (eds. Nakao, K., Minato, N. and Uemoto, S.). Springer, Tokyo, pp. 177\u2013186.","DOI":"10.1007\/978-4-431-55651-0_15"},{"key":"54","unstructured":"54) Nakao, K., Okubo, Y., Yasoda, A., Koyama, N., Osawa, K., Isobe, Y.  (2013) The Effects of C-type natriuretic peptide on craniofacial skeletogenesis. J. Dent. Res. 92, 58\u201364."},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Kondo, E., Yasoda, A., Fujii, T., Nakao, K., Yamashita, Y., Ueda-Sakane, Y.  (2015) Increased bone turnover and possible accelerated fracture healing in a murine model with an increased circulating C-type natriuretic peptide. Endocrinology 156, 2518\u20132529.","DOI":"10.1210\/en.2014-1801"},{"key":"56","unstructured":"56) Morii, N., Nakao, K., Sugawara, A., Sakamoto, M., Suda, M., Shimokura, M.  (1985) Occurrence of atrial natriuretic polypeptide in brain. Biochem. Biophys. Res. Commun. 127, 413\u2013419."},{"key":"57","doi-asserted-by":"publisher","unstructured":"57) Kawata, M., Nakao, K., Morii, N., Kiso, Y., Yamashita, H., Imura, H.  (1985) Atrial natriuretic polypeptide: Topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry. Neuroscience 16, 521\u2013546.","DOI":"10.1016\/0306-4522(85)90190-3"},{"key":"58","unstructured":"58) Morii, N., Nakao, K., Itoh, H., Shiono, S., Yamada, T., Sugawara, A.  (1987) Atrial natriuretic polypeptide in spinal cord and autonomic ganglia. Biochem. Biophys. Res. Commun. 145, 196\u2013203."},{"key":"59","unstructured":"59) Katsuura, G., Nakamura, M., Inouye, K., Kono, M., Nakao, K. and Imura, H. (1986) Regulatory role of atrial natriuretic polypeptide in water drinking in rats. Eur. J. Pharmacol. 121, 285\u2013287."},{"key":"60","unstructured":"60) Yamada, T., Nakao, K., Morii, N., Itoh, H., Shiono, S., Sakamoto, M.  (1986) Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats. Eur. J. Pharmacol. 125, 453\u2013456."},{"key":"61","unstructured":"61) Shirakami, G., Nakao, K., Yamada, T., Itoh, H., Mori, K., Kangawa, K.  (1988) Inhibitory effect of brain natriuretic peptide on central angiotensin II-stimulated pressor response in conscious rats. Neurosci. Lett. 91, 77\u201383."},{"key":"62","unstructured":"62) Shirakami, G., Itoh, H., Suga, S., Komatsu, Y., Hama, N., Mori, K.  (1993) Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats. Neurosci. Lett. 159, 25\u201328."},{"key":"63","unstructured":"63) Itoh, H., Nakao, K., Katsuura, G., Morii, N., Shiono, S., Sakamoto, M.  (1986) Centrally infused atrial natriuretic polypeptide attenuates exaggerated salt appetite in spontaneously hypertensive rats. Circ. Res. 59, 342\u2013347."},{"key":"64","unstructured":"64) Itoh, H., Nakao, K., Morii, N., Yamada, T., Shiono, S., Sakamoto, M.  (1986) Central action of atrial natriuretic polypeptide on blood pressure in conscious rats. Brain Res. Bull. 16, 745\u2013749."},{"key":"65","unstructured":"65) Itoh, H., Nakao, K., Yamada, T., Morii, N., Shiono, S., Sugawara, A.  (1988) Brain renin-angiotensin. Central control of secretion of atrial natriuretic factor from the heart. Hypertension 11, I57\u2013I61."},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Inuzuka, M., Tamura, N., Yamada, N., Katsuura, G., Oyamada, N., Taura, D.  (2010) C-type natriuretic peptide as a new regulator of food intake and energy expenditure. Endocrinology 151, 3633\u20133642.","DOI":"10.1210\/en.2010-0141"},{"key":"67","doi-asserted-by":"publisher","unstructured":"67) Yamada-Goto, N., Katsuura, G., Ebihara, K., Inuzuka, M., Ochi, Y., Yamashita, Y.  (2013) Intracerebroventricular administration of C-type natriuretic peptide suppresses food intake via activation of the melanocortin system in mice. Diabetes 62, 1500\u20131504.","DOI":"10.2337\/db12-0718"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Yamashita, Y., Yamada-Goto, N., Katsuura, G., Ochi, Y., Kanai, Y., Miyazaki, Y.  (2016) Brain-specific natriuretic peptide receptor-B deletion attenuates high-fat diet-induced visceral and hepatic lipid deposition in mice. Peptides 81, 38\u201350.","DOI":"10.1016\/j.peptides.2016.03.014"},{"key":"69","doi-asserted-by":"publisher","unstructured":"69) Steinhelper, M.E., Cochrane, K.L. and Field, L.J. (1990) Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16, 301\u2013307.","DOI":"10.1161\/01.HYP.16.3.301"},{"key":"70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1126\/science.7839143","volume":"267","author":"S.W. John","year":"1995","unstructured":"70) John, S.W., Krege, J.H., Oliver, P.M., Hagaman, J.R., Hodgin, J.B., Pang, S.C.  (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267, 679\u2013681.","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Ogawa, Y., Itoh, H., Tamura, N., Suga, S., Yoshimasa, T., Uehira, M.  (1994) Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J. Clin. Invest. 93, 1911\u20131921.","DOI":"10.1172\/JCI117182"},{"key":"72","unstructured":"72) Tamura, N., Ogawa, Y., Chusho, H., Nakamura, K., Nakao, K., Suda, M.  (2000) Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. U.S.A. 97, 4239\u20134244."},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Lopez, M.J., Wong, S.K., Kishimoto, I., Dubois, S., Mach, V., Friesen, J.  (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 8, 65\u201368.","DOI":"10.1038\/378065a0"},{"key":"74","unstructured":"74) Suganami, T., Mukoyama, M., Sugawara, A., Mori, K., Nagae, T., Kasahara, M.  (2001) Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J. Am. Soc. Nephrol. 12, 2652\u20132663."},{"key":"75","unstructured":"75) Kasahara, M., Mukoyama, M., Sugawara, A., Makino, H., Suganami, T., Ogawa, Y.  (2000) Ameliorated glomerular injury in mice overexpressing brain natriuretic peptide with renal ablation. J. Am. Soc. Nephrol. 11, 1691\u20131701."},{"key":"76","doi-asserted-by":"publisher","unstructured":"76) Makino, H., Mukoyama, M., Mori, K., Suganami, T., Kasahara, M., Yahata, K.  (2006) Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia 49, 2514\u20132524.","DOI":"10.1007\/s00125-006-0352-y"},{"key":"77","unstructured":"77) Suda, M., Ogawa, Y., Tanaka, K., Tamura, N., Yasoda, A., Takigawa, T.  (1998) Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc. Natl. Acad. Sci. U.S.A. 95, 2337\u20132342."},{"key":"78","doi-asserted-by":"publisher","unstructured":"78) Chusho, H., Ogawa, Y., Tamura, N., Suda, M., Yasoda, A., Miyazawa, T.  (2000) Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways. Endocrinology 141, 3807\u20133813.","DOI":"10.1210\/en.141.10.3807"},{"key":"79","unstructured":"79) Oliver, P.M., Fox, J.E., Kim, R., Rockman, H.A., Kim, H.S., Reddick, R.L.  (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. U.S.A. 94, 14730\u201314735."},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Knowles, J.W., Esposito, G., Mao, L., Hagaman, J.R., Fox, J.E., Smithies, O.  (2001) Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J. Clin. Invest. 107, 975\u2013984.","DOI":"10.1172\/JCI11273"},{"key":"81","unstructured":"81) Kishimoto, I., Rossi, K. and Garbers, D.L. (2001) A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 98, 2703\u20132706."},{"key":"82","unstructured":"82) Holtwick, R., Gotthardt, M., Skryabin, B., Steinmetz, M., Potthast, R., Zetsche, B.  (2002) Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc. Natl. Acad. Sci. U.S.A. 99, 7142\u20137147."},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Holtwick, R., van Eickels, M., Skryabin, B.V., Baba, H.A., Bubikat, A., Begrow, F.  (2003) Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J. Clin. Invest. 111, 1399\u20131407.","DOI":"10.1172\/JCI17061"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Sabrane, K., Kruse, M.N., Fabritz, L., Zetsche, B., Mitko, D., Skryabin, B.V.  (2005) Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J. Clin. Invest. 115, 1666\u20131674.","DOI":"10.1172\/JCI23360"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Tamura, N., Ogawa, Y., Yasoda, A., Itoh, H., Saito, Y. and Nakao, K. (1996) Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J. Mol. Cell. Cardiol. 28, 1811\u20131815.","DOI":"10.1006\/jmcc.1996.0170"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Kuwahara, K., Saito, Y., Ogawa, E., Takahashi, N., Nakagawa, Y., Naruse, Y.  (2001) The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol. Cell. Biol. 21, 2085\u20132097.","DOI":"10.1128\/MCB.21.6.2085-2097.2001"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Kuwahara, K., Saito, Y., Takano, M., Arai, Y., Yasuno, S., Nakagawa, Y.  (2003) NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 22, 6310\u20136321.","DOI":"10.1093\/emboj\/cdg601"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Yasuno, S., Usami, S., Kuwahara, K., Nakanishi, M., Arai, Y., Kinoshita, H.  (2009) Endogenous cardiac natriuretic peptides protect the heart in a mouse model of dilated cardiomyopathy and sudden death. Am. J. Physiol. Heart Circ. Physiol. 296, H1804\u2013H1810.","DOI":"10.1152\/ajpheart.01033.2008"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Kuwahara, K., Kinoshita, H., Kuwabara, Y., Nakagawa, Y., Usami, S., Minami, T.  (2010) Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol. Cell. Biol. 30, 4134\u20134148.","DOI":"10.1128\/MCB.00154-10"},{"key":"90","unstructured":"90) Tamura, N., Doolittle, L.K., Hammer, R.E., Shelton, J.M., Richardson, J.A. and Garbers, D.L. (2004) Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc. Natl. Acad. Sci. U.S.A. 101, 17300\u201317305."},{"key":"91","unstructured":"91) Langenickel, T.H., Buttgereit, J., Pagel-Langenickel, I., Lindner, M., Monti, J., Beuerlein, K.  (2006) Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc. Natl. Acad. Sci. U.S.A. 103, 4735\u20134740."},{"key":"92","doi-asserted-by":"crossref","unstructured":"92) Feil, R., Lohmann, S.M., de Jonge, H., Walter, U. and Hofmann, F. (2003) Cyclic GMP-dependent protein kinases and the cardiovascular system: Insights from genetically modified mice. Circ. Res. 93, 907\u2013916.","DOI":"10.1161\/01.RES.0000100390.68771.CC"},{"key":"93","doi-asserted-by":"publisher","unstructured":"93) Pfeifer, A., Aszodi, A., Seidler, U., Ruth, P., Hofmann, F. and Fassler, R. (1996) Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 274, 2082\u20132086.","DOI":"10.1126\/science.274.5295.2082"},{"key":"94","doi-asserted-by":"publisher","unstructured":"94) Miyazawa, T., Ogawa, Y., Chusho, H., Yasoda, A., Tamura, N., Komatsu, Y.  (2002) Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Endocrinology 143, 3604\u20133610.","DOI":"10.1210\/en.2002-220307"},{"key":"95","unstructured":"95) Tsuji, T. and Kunieda, T. (2005) A loss-of-function mutation in natriuretic peptide receptor 2 (<i>Npr2<\/i>) gene is responsible for disproportionate dwarfism in <i>cn\/cn<\/i> mouse. J. Biol. Chem. 280, 14288\u201314292."},{"key":"96","doi-asserted-by":"crossref","unstructured":"96) Sogawa, C., Tsuji, T., Shinkai, Y., Katayama, K. and Kunieda, T. (2007) Short-limbed dwarfism: <i>slw<\/i> is a new allele of <i>Npr2<\/i> causing chondrodysplasia. J. Hered. 98, 575\u2013580.","DOI":"10.1093\/jhered\/esm065"},{"key":"97","unstructured":"97) Tsuji, T., Kondo, E., Yasoda, A., Inamoto, M., Kiyosu, C., Nakao, K.  (2008) Hypomorphic mutation in mouse Nppc gene causes retarded bone growth due to impaired endochondral ossification. Biochem. Biophys. Res. Commun. 376, 186\u2013190."},{"key":"98","doi-asserted-by":"crossref","unstructured":"98) Jiao, Y., Yan, J., Jiao, F., Yang, H., Donahue, L.R., Li, X.  (2007) A single nucleotide mutation in Nppc is associated with a long bone abnormality in lbab mice. BMC Genet. 8, 16.","DOI":"10.1186\/1471-2156-8-16"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99) Kondo, E., Yasoda, A., Tsuji, T., Fujii, T., Miura, M., Kanamoto, N.  (2012) Skeletal analysis of the long bone abnormality (lbab\/lbab) mouse, a novel chondrodysplastic C-type natriuretic peptide mutant. Calcif. Tissue Int. 90, 307\u2013318.","DOI":"10.1007\/s00223-011-9567-0"},{"key":"100","unstructured":"100) Nakao, K., Osawa, K., Yasoda, A., Yamanaka, S., Fujii, T., Kondo, E.  (2015) The local CNP\/GC-B system. In growth plate is responsible for physiological endochondral bone growth. Sci. Rep. 5, 10554."},{"key":"101","doi-asserted-by":"crossref","unstructured":"101) Fujii, T., Hirota, K., Yasoda, A., Takizawa, A., Morozumi, N., Nakamura, R.  (2018) Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death. PLoS One 22, e0194812.","DOI":"10.1371\/journal.pone.0194812"},{"key":"102","unstructured":"102) Yamanaka, S., Nakao, K., Koyama, N., Isobe, Y., Ueda, Y., Kanai, Y.  (2017) Circulatory CNP Rescues Craniofacial Hypoplasia in Achondroplasia. J. Dent. Res. 96, 1526\u20131534."},{"key":"103","unstructured":"103) Superti-Furga, A., Bonafe, L. and Rimoin, D.L. (2001) Molecular-pathogenetic classification of genetic disorders of the skeleton. Am. J. Med. Genet. 106, 282\u2013293."},{"key":"104","doi-asserted-by":"publisher","unstructured":"104) Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.M., Maroteaux, P.  (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252\u2013254.","DOI":"10.1038\/371252a0"},{"key":"105","unstructured":"105) Cattaneo, R., Villa, A., Catagni, M. and Tentori, L. (1988) Limb lengthening in achondroplasia by Ilizarov\u2019s method. Int. Orthop. 12, 173\u2013179."},{"key":"106","unstructured":"106) Kake, T., Kitamura, H., Adachi, Y., Yoshioka, T., Watanabe, T., Matsushita, H.  (2009) Chronically elevated plasma C-type natriuretic peptide (CNP) level stimulates skeletal growth in transgenic mice. Am. J. Physiol. Endocrinol. Metab. 297, E1339\u2013E1348."},{"key":"107","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/en.2008-1676","volume":"150","author":"A. Yasoda","year":"2009","unstructured":"107) Yasoda, A., Kitamura, H., Fujii, T., Kondo, E., Murao, N., Miura, M.  (2009) Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology 150, 3138\u20133144.","journal-title":"Endocrinology","ISSN":"http:\/\/id.crossref.org\/issn\/0013-7227","issn-type":"print"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108) Fujii, T., Komatsu, Y., Yasoda, A., Kondo, E., Yoshioka, T., Nambu, T.  (2010) Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death. Endocrinology 151, 4381\u20134388.","DOI":"10.1210\/en.2010-0078"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109) Igaki, T., Itoh, H., Suga, S.I., Hama, N., Ogawa, Y., Komatsu, Y.  (1998) Effects of intravenously administered C-type natriuretic peptide in humans: Comparison with atrial natriuretic peptide. Hypertens. Res. 21, 7\u201313.","DOI":"10.1291\/hypres.21.7"},{"key":"110","unstructured":"110) Bartels, C.F., Bukulmez, H., Padayatti, P., Rhee, D.K., van Ravenswaaij-Arts, C., Pauli, R.M.  (2004) Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am. J. Hum. Genet. 75, 27\u201334."},{"key":"111","doi-asserted-by":"crossref","unstructured":"111) Wendt, D.J., Dvorak-Ewell, M., Bullens, S., Lorget, F., Bell, S.M., Peng, J.  (2015) Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism. J. Pharmacol. Exp. Ther. 353, 132\u2013149.","DOI":"10.1124\/jpet.114.218560"},{"key":"112","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","volume":"372","author":"Y. Zhang","year":"1994","unstructured":"112) Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. and Friedman, J.M. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425\u2013432.","journal-title":"?Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"113","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"J.M. Friedman","year":"1998","unstructured":"113) Friedman, J.M. and Halaas, J.L. (1998) Leptin and the regulation of body weight in mammals. Nature 395, 763\u2013770.","journal-title":"?Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"114","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","volume":"269","author":"M.A. Pelleymounter","year":"1995","unstructured":"114) Pelleymounter, M.A., Cullen, M.J., Baker, M.B., Hecht, R., Winters, D., Boone, T.  (1995) Effects of the obese gene product on body weight regulation in ob\/ob mice. Science 269, 540\u2013543.","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.7624777","volume":"269","author":"J.L. Halaas","year":"1995","unstructured":"115) Halaas, J.L., Gajiwala, K.S., Maffei, M., Cohen, S.L., Chait, B.T., Rabinowitz, D.  (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543\u2013546.","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"116","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1126\/science.7624778","volume":"269","author":"L.A. Campfield","year":"1995","unstructured":"116) Campfield, L.A., Smith, F.J., Guisez, Y., Devos, R. and Burn, P. (1995) Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546\u2013549.","journal-title":"Science","ISSN":"http:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"117","doi-asserted-by":"publisher","unstructured":"117) Satoh, N., Ogawa, Y., Katsuura, G., Numata, Y., Tsuji, T., Hayase, M.  (1999) Sympathetic activation of leptin via the ventromedial hypothalamus: Leptin-induced increase in catecholamine secretion. Diabetes 48, 1787\u20131793.","DOI":"10.2337\/diabetes.48.9.1787"},{"key":"118","doi-asserted-by":"publisher","unstructured":"118) Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R.  (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263\u20131271.","DOI":"10.1016\/0092-8674(95)90151-5"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119) Ogawa, Y., Masuzaki, H., Isse, N., Okazaki, T., Mori, K., Shigemoto, M.  (1995) Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa\/fa) rats. J. Clin. Invest. 96, 1647\u20131652.","DOI":"10.1172\/JCI118204"},{"key":"120","unstructured":"120) Takaya, K., Ogawa, Y., Hiraoka, J., Hosoda, K., Yamori, Y., Nakao, K.  (1996) Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat. Genet. 14, 130\u2013131."},{"key":"121","doi-asserted-by":"crossref","unstructured":"121) Frederich, R.C., Hamann, A., Anderson, S., Lollmann, B., Lowell, B.B. and Flier, J.S. (1995) Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat. Med. 1, 1311\u20131314.","DOI":"10.1038\/nm1295-1311"},{"key":"122","doi-asserted-by":"crossref","unstructured":"122) Maffei, M., Halaas, J., Ravussin, E., Pratley, R.E., Lee, G.H., Zhang, Y.  (1995) Leptin levels in human and rodent: Measurement of plasma leptin and <i>ob<\/i> RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155\u20131161.","DOI":"10.1038\/nm1195-1155"},{"key":"123","unstructured":"123) Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R.  (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334, 292\u2013295."},{"key":"124","unstructured":"124) Isse, N., Ogawa, Y., Tamura, N., Masuzaki, H., Mori, K., Okazaki, T.  (1995) Structural organization and chromosomal assignment of the human obese gene. J. Biol. Chem. 270, 27728\u201327733."},{"key":"125","doi-asserted-by":"publisher","unstructured":"125) Satoh, N., Ogawa, Y., Katsuura, G., Tsuji, T., Masuzaki, H., Hiraoka, J.  (1997) Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: Evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology 138, 947\u2013954.","DOI":"10.1210\/en.138.3.947"},{"key":"126","unstructured":"126) Imagawa, K., Numata, Y., Katsuura, G., Sakaguchi, I., Morita, A., Kikuoka, S.  (1998) Structure-function studies of human leptin. J. Biol. Chem. 273, 35245\u201335249."},{"key":"127","doi-asserted-by":"publisher","unstructured":"127) Caro, J.F., Kolaczynski, J.W., Nyce, M.R., Ohannesian, J.P., Opentanova, I., Goldman, W.H.  (1996) Decreased cerebrospinal-fluid\/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348, 159\u2013161.","DOI":"10.1016\/S0140-6736(96)03173-X"},{"key":"128","unstructured":"128) Halaas, J.L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D.A. and Friedman, J.M. (1997) Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. U.S.A. 94, 8878\u20138883."},{"key":"129","doi-asserted-by":"crossref","unstructured":"129) Tanaka, T., Masuzaki, H., Yasue, S., Ebihara, K., Shiuchi, T., Ishii, T.  (2007) Central melanocortin signaling restores skeletal muscle AMP-activated protein kinase phosphorylation in mice fed a high-fat diet. Cell Metab. 5, 395\u2013402.","DOI":"10.1016\/j.cmet.2007.04.004"},{"key":"130","doi-asserted-by":"publisher","unstructured":"130) Montague, C.T., Farooqi, I.S., Whitehead, J.P., Soos, M.A., Rau, H., Wareham, N.J.  (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903\u2013908.","DOI":"10.1038\/43185"},{"key":"131","unstructured":"131) Strobel, A., Issad, T., Camoin, L., Ozata, M. and Strosberg, A.D. (1998) A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 18, 213\u2013215."},{"key":"132","doi-asserted-by":"crossref","unstructured":"132) Yura, S., Ogawa, Y., Sagawa, N., Masuzaki, H., Itoh, H., Ebihara, K.  (2000) Accelerated puberty and late-onset hypothalamic hypogonadism in female transgenic skinny mice overexpressing leptin. J. Clin. Invest. 105, 749\u2013755.","DOI":"10.1172\/JCI8353"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133) Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H.  (2000) Pathophysiological role of leptin in obesity-related hypertension. J. Clin. Invest. 105, 1243\u20131252.","DOI":"10.1172\/JCI8341"},{"key":"134","unstructured":"134) Elefteriou, F., Takeda, S., Ebihara, K., Magre, J., Patano, N., Kim, C.A.  (2004) Serum leptin level is a regulator of bone mass. Proc. Natl. Acad. Sci. U.S.A. 101, 3258\u20133263."},{"key":"135","doi-asserted-by":"crossref","unstructured":"135) Suganami, T., Mukoyama, M., Mori, K., Yokoi, H., Koshikawa, M., Sawai, K.  (2005) Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy. FASEB J. 19, 127\u2013129.","DOI":"10.1096\/fj.04-2183fje"},{"key":"136","unstructured":"136) Masuzaki, H., Ogawa, Y., Hosoda, K., Miyawaki, T., Hanaoka, I., Hiraoka, J.  (1997) Glucocorticoid regulation of leptin synthesis and secretion in humans: Elevated plasma leptin levels in Cushing\u2019s syndrome. J. Clin. Endocrinol. Metab. 82, 2542\u20132547."},{"key":"137","unstructured":"137) Nakao, K. (2009) Adiposcience and adipotoxicity. Nat. Clin. Pract. Endocrinol. Metab. 5, 63."},{"key":"138","doi-asserted-by":"crossref","unstructured":"138) Ebihara, K. and Nakao, K. (2015) Translational research of leptin in lipodystrophy and its related diseases. <i>In<\/i> Innovative Medicine: Basic Research and Development (eds. Nakao, K., Minato, N. and Uemoto, S.). Springer, Tokyo, pp. 165\u2013175.","DOI":"10.1007\/978-4-431-55651-0_14"},{"key":"139","doi-asserted-by":"crossref","unstructured":"139) Masuzaki, H., Ogawa, Y., Sagawa, N., Hosoda, K., Matsumoto, T., Mise, H.  (1997) Nonadipose tissue production of leptin: Leptin as a novel placenta-derived hormone in humans. Nat. Med. 3, 1029\u20131033.","DOI":"10.1038\/nm0997-1029"},{"key":"140","doi-asserted-by":"crossref","unstructured":"140) Sagawa, N., Mori, T., Masuzaki, H., Ogawa, Y. and Nakao, K. (1997) Leptin production by hydatidiform mole. Lancet 350, 1518\u20131519.","DOI":"10.1016\/S0140-6736(05)63940-2"},{"key":"141","doi-asserted-by":"publisher","unstructured":"141) Ogawa, Y., Masuzaki, H., Hosoda, K., Aizawa-Abe, M., Suga, J., Suda, M.  (1999) Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48, 1822\u20131829.","DOI":"10.2337\/diabetes.48.9.1822"},{"key":"142","doi-asserted-by":"publisher","unstructured":"142) Masuzaki, H., Ogawa, Y., Isse, N., Satoh, N., Okazaki, T., Shigemoto, M.  (1995) Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44, 855\u2013858.","DOI":"10.2337\/diabetes.44.7.855"},{"key":"143","unstructured":"143) Ioffe, E., Moon, B., Connolly, E. and Friedman, J.M. (1998) Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc. Natl. Acad. Sci. U.S.A. 95, 11852\u201311857."},{"key":"144","doi-asserted-by":"publisher","unstructured":"144) Masuzaki, H., Ogawa, Y., Aizawa-Abe, M., Hosoda, K., Suga, J., Ebihara, K.  (1999) Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: Usefulness of leptin for the treatment of obesity-associated diabetes. Diabetes 48, 1615\u20131622.","DOI":"10.2337\/diabetes.48.8.1615"},{"key":"145","doi-asserted-by":"publisher","unstructured":"145) Tanaka, T., Hidaka, S., Masuzaki, H., Yasue, S., Minokoshi, Y., Ebihara, K.  (2005) Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification. Diabetes 54, 2365\u20132374.","DOI":"10.2337\/diabetes.54.8.2365"},{"key":"146","doi-asserted-by":"crossref","unstructured":"146) Masuda, S., Tanaka, T., Masuzaki, H., Nakao, K. and Taguchi, S. (2014) Overexpression of leptin reduces the ratio of glycolytic to oxidative enzymatic activities without changing muscle fiber types in mouse skeletal muscle. Biol. Pharm. Bull. 37, 169\u2013173.","DOI":"10.1248\/bpb.b13-00557"},{"key":"147","doi-asserted-by":"publisher","unstructured":"147) Kamohara, S., Burcelin, R., Halaas, J.L., Friedman, J.M. and Charron, M.J. (1997) Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389, 374\u2013377.","DOI":"10.1038\/38717"},{"key":"148","unstructured":"148) Liu, L., Karkanias, G.B., Morales, J.C., Hawkins, M., Barzilai, N., Wang, J.  (1998) Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J. Biol. Chem. 273, 31160\u201331167."},{"key":"149","doi-asserted-by":"publisher","unstructured":"149) Cusin, I., Zakrzewska, K.E., Boss, O., Muzzin, P., Giacobino, J.P., Ricquier, D.  (1998) Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 47, 1014\u20131019.","DOI":"10.2337\/diabetes.47.7.1014"},{"key":"150","unstructured":"150) Goldstein, B.J. (1994) Syndrome of extreme insulin resistance. <i>In<\/i> Joslin\u2019s Diabetes Mellitus, 13th ed. (eds. Joslin, E.P., Kahn, C.R. and Weir, G.C.). Lea &amp; Febiger, Philadelphia."},{"key":"151","unstructured":"151) Andreelli, F., Hanaire-Broutin, H., Laville, M., Tauber, J.P., Riou, J.P. and Thivolet, C. (2000) Normal reproductive function in leptin-deficient patients with lipoatropic diabetes. J. Clin. Endocrinol. Metab. 85, 715\u2013719."},{"key":"152","unstructured":"152) Pardini, V.C., Victoria, I.M., Rocha, S.M., Andrade, D.G., Rocha, A.M., Pieroni, F.B.  (1998) Leptin levels, \u03b2-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes. J. Clin. Endocrinol. Metab. 83, 503\u2013508."},{"key":"153","doi-asserted-by":"crossref","unstructured":"153) Moitra, J., Mason, M.M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B.  (1998) Life without white fat: A transgenic mouse. Genes Dev. 12, 3168\u20133181.","DOI":"10.1101\/gad.12.20.3168"},{"key":"154","doi-asserted-by":"crossref","unstructured":"154) Shimomura, I., Hammer, R.E., Richardson, J.A., Ikemoto, S., Bashmakov, Y., Goldstein, J.L.  (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy. Genes Dev. 12, 3182\u20133194.","DOI":"10.1101\/gad.12.20.3182"},{"key":"155","doi-asserted-by":"publisher","unstructured":"155) Ebihara, K., Ogawa, Y., Masuzaki, H., Shintani, M., Miyanaga, F., Aizawa-Abe, M.  (2001) Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 50, 1440\u20131448.","DOI":"10.2337\/diabetes.50.6.1440"},{"key":"156","doi-asserted-by":"publisher","unstructured":"156) Kobayashi, H., Ogawa, Y., Shintani, M., Ebihara, K., Shimodahira, M., Iwakura, T.  (2002) A Novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes 51, 243\u2013246.","DOI":"10.2337\/diabetes.51.1.243"},{"key":"157","doi-asserted-by":"crossref","unstructured":"157) Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B. and Froguel, P. (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 106, 253\u2013262.","DOI":"10.1172\/JCI9238"},{"key":"158","doi-asserted-by":"crossref","unstructured":"158) Farooqi, I.S., Yeo, G.S., Keogh, J.M., Aminian, S., Jebb, S.A., Butler, G.  (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J. Clin. Invest. 106, 271\u2013279.","DOI":"10.1172\/JCI9397"},{"key":"159","unstructured":"159) Ebihara, K., Masuzaki, H. and Nakao, K. (2004) Long-term leptin-replacement therapy for lipoatrophic diabetes. N. Engl. J. Med. 351, 615\u2013616."},{"key":"160","unstructured":"160) Ebihara, K., Kusakabe, T., Hirata, M., Masuzaki, H., Miyanaga, F., Kobayashi, N.  (2007) Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy. J. Clin. Endocrinol. Metab. 92, 532\u2013541."},{"key":"161","unstructured":"161) Oral, E.A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P.  (2002) Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med. 346, 570\u2013578."},{"key":"162","unstructured":"162) Aotani, D., Ebihara, K., Sawamoto, N., Kusakabe, T., Aizawa-Abe, M., Kataoka, S.  (2012) Functional magnetic resonance imaging analysis of food-related brain activity in patients with lipodystrophy undergoing leptin replacement therapy. J. Clin. Endocrinol. Metab. 97, 3663\u20133671."},{"key":"163","unstructured":"163) Brown, R.J., Araujo-Vilar, D., Cheung, P.T., Dunger, D., Garg, A., Jack, M.  (2016) The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline. J. Clin. Endocrinol. Metab. 101, 4500\u20134511."},{"key":"164","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.metabol.2009.04.043","volume":"58","author":"M. Iwanishi","year":"2009","unstructured":"164) Iwanishi, M., Ebihara, K., Kuskabe, T., Chen, W., Ito, J., Masuzaki, H.  (2009) Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy. Metabolism 58, 1681\u20131687.","journal-title":"Metabolism Clinical and Experimental","ISSN":"http:\/\/id.crossref.org\/issn\/0026-0495","issn-type":"print"},{"key":"165","unstructured":"165) Iwanishi, M., Ebihara, K., Kusakabe, T., Harada, S., Ito-Kobayashi, J., Tsuji, A.  (2012) Premature atherosclerosis in a Japanese diabetic patient with atypical familial partial lipodystrophy and hypertriglyceridemia. Intern. Med. 51, 2573\u20132579."},{"key":"166","unstructured":"166) Shibata, Y., Nakatsukasa, A., Eguchi, J., Miyamoto, S., Masuda, Y., Awazawa, M.  (2018) Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: Two case reports. J. Med. Case Reports 12, 368\u2013372."},{"key":"167","doi-asserted-by":"publisher","unstructured":"167) Miyanaga, F., Ogawa, Y., Ebihara, K., Hidaka, S., Tanaka, T., Hayashi, S.  (2003) Leptin as an adjunct of insulin therapy in insulin-deficient diabetes. Diabetologia 46, 1329\u20131337.","DOI":"10.1007\/s00125-003-1193-6"},{"key":"168","doi-asserted-by":"crossref","unstructured":"168) Naito, M., Fujikura, J., Ebihara, K., Miyanaga, F., Yokoi, H., Kusakabe, T.  (2011) Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice. Diabetes 60, 2265\u20132273.","DOI":"10.2337\/db10-1795"},{"key":"169","doi-asserted-by":"publisher","unstructured":"169) Kusakabe, T., Tanioka, H., Ebihara, K., Hirata, M., Miyamoto, L., Miyanaga, F.  (2009) Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet. Diabetologia 52, 675\u2013683.","DOI":"10.1007\/s00125-009-1258-2"},{"key":"170","unstructured":"170) Shimizu, Y., Son, C., Aotani, D., Nomura, H., Hikida, T., Hosoda, K.  (2017) Role of leptin in conditioned place preference to high-fat diet in leptin-deficient ob\/ob mice. Neurosci. Lett. 640, 60\u201363."},{"key":"171","doi-asserted-by":"crossref","unstructured":"171) Yamada, N., Katsuura, G., Ochi, Y., Ebihara, K., Kusakabe, T., Hosoda, K.  (2011) Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152, 2634\u20132643.","DOI":"10.1210\/en.2011-0004"},{"key":"172","unstructured":"172) Miyamoto, L., Ebihara, K., Kusakabe, T., Aotani, D., Yamamoto-Kataoka, S., Sakai, T.  (2012) Leptin activates hepatic 5\u2032 AMP-Activated Protein Kinase through sympathetic nervous system and \u03b11 adrenergic receptor: A potential mechanism for improvement of fatty liver in lipodystrophy by leptin. J. Biol. Chem. 287, 40441\u201340447."},{"key":"173","unstructured":"173) Yamamoto-Kataoka, S., Ebihara, K., Aizawa-Abe, M., Nishio, M., Kusakabe, T., Yamamoto, Y.  (2015) Leptin improves fatty liver independently of insulin sensitization and appetite suppression in hepatocyte-specific pten-deficient mice with insulin hypersensitivity. Horm. Metab. Res. 47, 168\u2013175."},{"key":"174","unstructured":"174) Aizawa-Abe, M., Ebihara, K., Ebihara, C., Mashimo, T., Takizawa, A., Tomita, T.  (2013) Generation of leptin deficient Lepmkyo\/Lepmkyo rats and identification of leptin responsive genes in the liver. Physiol. Genomics 45, 786\u2013793."},{"key":"175","unstructured":"175) Ebihara, C., Ebihara, K., Aizawa-Abe, M., Mashimo, T., Tomita, T., Zhao, M.  (2015) Seipin is necessary for normal brain development and spermatogenesis in addition to adipogesis. Hum. Mol. Genet. 24, 4238\u20134249."},{"key":"176","doi-asserted-by":"crossref","unstructured":"176) Kusakabe, T., Ebihara, K., Sakai, T., Miyamoto, L., Aotani, D., Yamamoto, Y.  (2012) Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice. Am. J. Physiol. Endocrinol. Metab. 302, E924\u2013E931.","DOI":"10.1152\/ajpendo.00198.2011"},{"key":"177","doi-asserted-by":"crossref","unstructured":"177) Sakai, T., Kusakabe, T., Ebihara, K., Aotani, D., Yamamoto-Kataoka, S., Zhao, M.  (2014) Leptin restores the insulinotropic effect of exenatide in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and high-fat diet. Am. J. Physiol. Endocrinol. Metab. 307, E712\u2013E719.","DOI":"10.1152\/ajpendo.00272.2014"},{"key":"178","doi-asserted-by":"crossref","unstructured":"178) Liu, J., Lee, J., Salazar Hernandez, M.A., Mazitschek, R. and Ozcan, U. (2015) Treatment of obesity with celastrol. Cell 161, 999\u20131011.","DOI":"10.1016\/j.cell.2015.05.011"},{"key":"179","unstructured":"179) Lee, J., Lie, J., Feng, X., Salazar Hernandez, M.A., Mucka, P., Choi, J.W.  (2016) Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice. Nat. Med. 22, 1023\u20131032."},{"key":"180","doi-asserted-by":"crossref","unstructured":"180) Chellappa, K., Perron, I.J., Naidoo, N. and Baur, J.A. (2019) The leptin sensitizer celastrol reduces age-associated obesity and modulates behavioral rhythm. Aging Cell 18, e12874.","DOI":"10.1111\/acel.12874"},{"key":"181","doi-asserted-by":"crossref","unstructured":"181) Iwakura, H., Dote, K., Bando, M., Koyama, H., Hosoda, K., Kangawa, K.  (2016) Establishment of leptin-responsive cell lines from adult mouse hypothalamus. PLoS One 11, e0148639.","DOI":"10.1371\/journal.pone.0148639"},{"key":"182","doi-asserted-by":"crossref","unstructured":"182) Nakao, K., Nakai, Y., Oki, S., Horii, K. and Imura, H. (1978) Presence of immunoreactive \u03b2-endorphin in normal human plasma: A concomitant release of \u03b2-endorphin with adrenocorticotropin after metyrapone administration. J. Clin. Invest. 62, 1395\u20131398.","DOI":"10.1172\/JCI109261"},{"key":"183","unstructured":"183) Nakao, K., Nakai, Y., Jingami, H., Oki, S., Fukata, J. and Imura, H. (1979) Substantial rise of plasma \u03b2-endorphin levels after insulin-induced hypoglycemia in human subjects. J. Clin. Endocrinol. Metab. 49, 838\u2013841."},{"key":"184","doi-asserted-by":"crossref","unstructured":"184) Nakao, K., Oki, S., Tanaka, I., Horii, K., Nakai, Y., Furui, T.  (1980) Immunoreactive \u03b2-endorphin and adrenocorticotropin in human cerebrospinal fluid. J. Clin. Invest. 66, 1383\u20131390.","DOI":"10.1172\/JCI109991"},{"key":"185","doi-asserted-by":"crossref","unstructured":"185) Yoshimasa, T., Nakao, K., Ohtsuki, H., Li, S. and Imura, H. (1982) Methionine-enkephalin and leucine-enkephalin in human sympathoadrenal system and pheochromocytoma. J. Clin. Invest. 69, 643\u2013650.","DOI":"10.1172\/JCI110491"},{"key":"186","unstructured":"186) Yoshimasa, T., Nakao, K., Li, S., Ikeda, Y., Suda, M., Sakamoto, M.  (1983) Plasma methionine-enkephalin and leucine-enkephalin in normal subjects and patients with pheochromocytoma. J. Clin. Endocrinol. Metab. 57, 706\u2013712."},{"key":"187","unstructured":"187) Nakao, K., Suda, M., Sakamoto, M., Yoshimasa, T., Morii, N., Ikeda, Y.  (1983) Leumorphin is a novel endogenous opioid peptide derived from preproenkephalin B. Biochem. Biophys. Res. Commun. 117, 695\u2013701."},{"key":"188","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000124637","volume":"44","author":"H. Imura","year":"1986","unstructured":"188) Imura, H., Nakao, K., Yanaihara, N., Katsuura, G. and Nakamura, M. (1986) Potent action of leumorphin on consummatory behaviors in rats: Comparison with other opioid peptides. Neuroendocrinology 44, 142\u2013148.","journal-title":"Neuroendocrinology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3835","issn-type":"print"},{"key":"189","doi-asserted-by":"crossref","unstructured":"189) Goldstein, J.L. and Brown, M.S. (1997) The clinical investigator: bewitched, bothered, and bewildered-but still beloved. J. Clin. Invest. 99, 2803\u20132812.","DOI":"10.1172\/JCI119470"}],"container-title":["Proceedings of the Japan Academy, Series B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/pjab\/95\/9\/95_PJA9509B-03\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T03:34:54Z","timestamp":1573875294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/pjab\/95\/9\/95_PJA9509B-03\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":189,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2183\/pjab.95.037","relation":{},"ISSN":["0386-2208","1349-2896"],"issn-type":[{"value":"0386-2208","type":"print"},{"value":"1349-2896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]}}}